- Home
- CWST vs CORT Comparison
CWST vs CORT Comparison
Compare CWST & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWST | CORT |
|---|---|---|
| Founded | 1975 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 8.6B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CWST | CORT |
|---|---|---|
| Price | $98.51 | $37.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $118.67 | $111.00 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 02-11-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | 0.24 | ★ 0.87 |
| Revenue | ★ $1,795,272,000.00 | $741,172,000.00 |
| Revenue This Year | $20.40 | $23.96 |
| Revenue Next Year | $7.63 | $43.40 |
| P/E Ratio | $410.51 | ★ $43.73 |
| Revenue Growth | ★ 20.54 | 17.92 |
| 52 Week Low | $82.22 | $32.99 |
| 52 Week High | $121.24 | $117.33 |
Technical Indicators
Market Signals| Indicator | CWST | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 52.86 | 17.53 |
| Support Level | $98.14 | $32.99 |
| Resistance Level | $102.51 | $85.34 |
| Average True Range (ATR) | 2.01 | 4.07 |
| MACD | -0.43 | -5.26 |
| Stochastic Oscillator | 20.94 | 8.23 |
Price Performance
Historical ComparisonAbout CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.